Edward Li
Impact in
-
- Cancer-related Molecular Pathways
- Neutropenia and Cancer Infections
-
- Biosimilars and Bioanalytical Methods
Papers in
-
- Biosimilars and Bioanalytical Methods 8
- Oncology 9
- Neutropenia and Cancer Infections 8
- Co-authors
- James M. Hoffman (4 shared papers)Cong Ran (1 shared paper)Whitney M. Cleghorn (1 shared paper)Jing Li (1 shared paper)Hui-Zi Chen (1 shared paper)Hasan Siddiqui (1 shared paper)Michael B. Weinstein (1 shared paper)Gustavo W. Leone (1 shared paper)
- Journals
- Journal of Managed Care & Specialty Pharmacy (6 papers)American Journal of Health-System Pharmacy (5 papers)Journal of the National Comprehensive Cancer Network (2 papers)Journal of the American Academy of Dermatology (2 papers)JCO Oncology Practice (2 papers)
- Partner nations
- United StatesJapanCanada
In The Last Decade
Edward Li
38 papers receiving 709 citations
Peers
Comparison fields: 5 of 122
- Oncology 161
- Immunology 101
- Clinical Biochemistry 31
- Geriatrics and Gerontology 14
- Molecular Biology 286
Countries citing papers authored by Edward Li
This map shows the geographic impact of Edward Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Li more than expected).
Fields of papers citing papers by Edward Li
This network shows the impact of papers produced by Edward Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Li. The network helps show where Edward Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 182 | |
| 2 | 2017 | 133 | |
| 3 | 2012 | 60 | |
| 4 | 2018 | 45 | |
| 5 | 2014 | 34 | |
| 6 | 2015 | 34 | |
| 7 | 2020 | 33 | |
| 8 | 2012 | 25 | |
| 9 | 2017 | 17 | |
| 10 | 2013 | 16 | |
| 11 | 2021 | 15 | |
| 12 | 2021 | 15 | |
| 13 | 2023 | 15 | |
| 14 | 2015 | 13 | |
| 15 | 2016 | 13 | |
| 16 | 2015 | 13 | |
| 17 | 2023 | 13 | |
| 18 | 2021 | 7 | |
| 19 | 2017 | 7 | |
| 20 | 2022 | 7 |
About Edward Li
Edward Li is a scholar working on Immunology, Oncology, Clinical Biochemistry, Dermatology and Economics and Econometrics, having authored 42 papers that have together received 742 indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (8 papers), Neutropenia and Cancer Infections (8 papers), Pharmaceutical Economics and Policy (4 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Financial Reporting and Valuation Research (2 papers), Student Assessment and Feedback (2 papers), Pharmaceutical studies and practices (2 papers) and Oral health in cancer treatment (2 papers). The work is most often cited by research in Oncology (161 citations), Immunology (101 citations), Clinical Biochemistry (31 citations), Geriatrics and Gerontology (14 citations) and Molecular Biology (286 citations). Edward Li has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include James M. Hoffman, Cong Ran, Whitney M. Cleghorn, Jing Li, Hui-Zi Chen, Hasan Siddiqui, Michael B. Weinstein, Gustavo W. Leone, Karl Kornacker and Chang‐Gong Liu. Their work appears in journals such as Journal of Managed Care & Specialty Pharmacy, American Journal of Health-System Pharmacy, Journal of the National Comprehensive Cancer Network, Journal of the American Academy of Dermatology and JCO Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.